Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Family Medicine

Intermittent Claudication Clinical Trials

A listing of Intermittent Claudication medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

State

Florida
Georgia
Kentucky
Minnesota
New York
North Carolina
Oklahoma
Rhode Island
Tennessee
Texas
Virginia

Country

Australia
Belgium
Denmark
France
Germany
Iceland
Italy
Netherlands
Poland
Singapore
Sweden
United Kingdom

Florida

Clearwater : Tampa Bay Medical Research

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Gainesville : Florida Researc Network, LLC

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Jacksonville : Jacksonville Center for Clinical Research

Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

Pinellas Park : DMI Research

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Georgia

Savannah : Memorial University Medical Center

The Investigational Plan for the Evaluation of the ACADIAâ„¢ Facet Replacement System (Pivotal IDE Trial) Protocol #1020-9052

Kentucky

Lexington : University of Kentucky Research Foundation

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Minnesota

Minneapolis : Cardiovascular Division, MMC, University of Minnesota

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

New York

New York : Cardiovascular Institute, Mount Sinai School of Medicine

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

North Carolina

Durham : Duke University

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Oklahoma

Oklahoma City : Saucedo,Jorge Felix

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Rhode Island

Warwick : Omega Medical Center

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Tennessee

Knoxville : Turkey Creek Medical Center

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Texas

San Antonio : Peripheral Vascular Associates

Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

San Antonio : Clinical Trials of Texas

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Virginia

Richmond : Novartis Investigative Site

Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease